These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 8725190

  • 1. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
    Shuter B, Tofts PS, Wang SC, Pope JM.
    Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
    [Abstract] [Full Text] [Related]

  • 2. Relaxivity of Gd-EOB-DTPA in the normal and biliary obstructed guinea pig.
    Shuter B, Wang SC, Roche J, Briggs G, Pope JM.
    J Magn Reson Imaging; 1998; 8(4):853-61. PubMed ID: 9702887
    [Abstract] [Full Text] [Related]

  • 3. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O, Mühler A, Vexler V, Berthezène Y, Brasch RC.
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [Abstract] [Full Text] [Related]

  • 4. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
    Benness G, Khangure M, Morris I, Warwick A, Burrows P, Vogler H, Weinmann HJ.
    Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
    [Abstract] [Full Text] [Related]

  • 5. Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.
    Krause W, Schuhmann-Giampieri G, Bauer M, Press WR, Muschick P.
    Invest Radiol; 1996 Aug; 31(8):502-11. PubMed ID: 8854197
    [Abstract] [Full Text] [Related]

  • 6. Ni-DTPA doped agarose gel--a phantom material for Gd-DTPA enhancement measurements.
    Tofts PS, Shuter B, Pope JM.
    Magn Reson Imaging; 1993 Aug; 11(1):125-33. PubMed ID: 8423715
    [Abstract] [Full Text] [Related]

  • 7. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
    Benness G, Khangure M, Morris I, Warwick A, Burrows P.
    Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
    [Abstract] [Full Text] [Related]

  • 8. Multinuclear MR characterization of a new hepatobiliary contrast agent. Preliminary results.
    Vander Elst L, Maton F, Laurent S, Seghi F, Muller RN.
    Acta Radiol Suppl; 1997 Aug; 412():135-8. PubMed ID: 9240092
    [Abstract] [Full Text] [Related]

  • 9. Elimination of gadolinium-ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats.
    Mühler A, Heinzelmann I, Weinmann HJ.
    Invest Radiol; 1994 Feb; 29(2):213-6. PubMed ID: 8169100
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G, Frenzel T, Schmitt-Willich H.
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue.
    Donahue KM, Burstein D, Manning WJ, Gray ML.
    Magn Reson Med; 1994 Jul; 32(1):66-76. PubMed ID: 8084239
    [Abstract] [Full Text] [Related]

  • 13. High resolution NMR imaging: Gd-DTPA labeled enzyme as a probe for permeability studies in polyacrylamide gels.
    Spanoghe M, Lanens D, Gorrebeeck C, Dommisse R, Lemière G, Van der Linden A, Van de Vyver F.
    Magn Reson Imaging; 1991 Jul; 9(4):583-7. PubMed ID: 1779730
    [Abstract] [Full Text] [Related]

  • 14. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
    Unger EC, Shen D, Wu G, Stewart L, Matsunaga TO, Trouard TP.
    MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats.
    Schmitz SA, Mühler A, Wagner S, Wolf KJ.
    Invest Radiol; 1996 Mar; 31(3):154-60. PubMed ID: 8675423
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of two new gadolinium chelates as contrast agents for MRI.
    Wiegers CB, Welch MJ, Sharp TL, Brown JJ, Perman WH, Sun Y, Motekaitis RJ, Martell AE.
    Magn Reson Imaging; 1992 Mar; 10(6):903-11. PubMed ID: 1461088
    [Abstract] [Full Text] [Related]

  • 19. Does gadolinium-diethylene triamine pentaacetic acid enhanced MRI of kidney represent tissue concentration of contrast media in the kidney? In vivo and in vitro study.
    Takeda M, Katayama Y, Tsutsui T, Komeyama T, Mizusawa T.
    Magn Reson Imaging; 1994 Mar; 12(3):421-7. PubMed ID: 8007771
    [Abstract] [Full Text] [Related]

  • 20. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
    Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U.
    Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.